Mr. Ilan Sobel reports

BIOHARVEST SCIENCES INC. ANNOUNCES GRANT OF STOCK OPTIONS AND ISSUANCE OF WARRANTS

Bioharvest Sciences Inc. has granted 1,287,500 incentive stock options to employees and 1,675,000 to consultants. The stock options granted are exercisable to purchase a common share of the company at a price of 20 cents per share for a term of 10 years and will vest as shown in the attached table.

Amount of stock options granted     Vesting terms

2,262,500                           Vesting quarterly over a three-year period
575,000                             Vesting quarterly over a two-year period
100,000                             Vesting quarterly over a one-year period 
25,000                              Vesting after three months

In addition, subject to the approval of the Canadian Securities Exchange, the company is issuing 2,274,500 warrants to a consultant in accordance with their agreement. The warrants will be valid until Oct. 25, 2025, and can be exercised to acquire a common share at a price 30 cents per share.

About Bioharvest Sciences Inc.

Bioharvest Sciences is a fast-growing biotech firm listed on the Canadian Securities Exchange. Bioharvest has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at industrial scale, without the need to grow the plant itself. Bioharvest is currently focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions, within two major business verticals -- nutraceutical health and wellness products, such as dietary supplements, and development of plant cell-based active pharmaceutical ingredients (APIs) that focus on specific medical indications.

We seek Safe Harbor.